Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 2, 2004, Pages 303-307

  Rex, André ^a   Schickert, Ralph ^a   Fink, Heidrun ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antidepressant; Behaviour; Forced swim test; NADH; Rat

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FORCED SWIMMING TEST; HYPERACTIVITY; IMMOBILIZATION; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 1642575180     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.11.001     Document Type: Article

References (27)

1. Anderson I.M., Tomenson B.M. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J. Psychopharmacol. 4:1994;238-249.
2. Beique J., de M., Blier P., Debonnel G. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat. Neuropharmacology. 39:2000;1800-1812.
3. Birkmayer J.G., Birkmayer W. The coenzyme nicotinamide adenine dinucleotide (NADH) as biological antidepressive agent: experience with 205 patients. New Trends Clin. Neuropharmacol. 5:1991;19-25.
4. Birkmayer J.G., Vrecko C., Volc D., Birkmayer W. Nicotinamide adenine dinucleotide (NADH) a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application. Acta Neurol. Scand. Suppl. 146:1993;32-35.
5. Blier P. Pharmacology of rapid-onset antidepressant treatment strategies. J. Clin. Psychiat. 62(Suppl. 15):2001;12-17.
6. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147-160.
7. Burke M.J., Preskorn S.H. Short-term treatment of mood disorders with standard antidepressants. Bloom F.E., Kupfer D.J. Psychopharmacology: the fourth generation of progress. 1995;1053-1067 Raven, New York.
8. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23:2002;238-245.
9. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121:1995;66-72.
10. Erecinska M., Wilson D.F. Regulation of cellular energy metabolism. J. Membr. Biol. 70:1982;1-14.
11. Forsyth L.M., Preuss H.G., MacDowell A.L., Chiazze L. Jr., Birkmayer G.D., Bellanti J.A. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann. Allergy Asthma Immunol. 82:1999;185-219.
12. Gardner A., Pagani M., Wibom R., Nennesmo I., Jacobsson H., Hallstrom T. Alterations of rCBF and mitochondrial dysfunction in major depressive disorder: a case report. Acta Psychiatr. Scand. 107:2003;233-239.
13. Kuhn W., Muller T., Winkel R. Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis. J. Neural Transm. 103:1996;1187-1193.
14. Krieger C., Duchen M.R. Mitochondria, Ca2+ and neurodegenerative disease. Eur. J. Pharmacol. 447:2002;177-188.
15. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 22:2000;191-199.
16. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8:1997;523-532.
17. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147:1999;162-167.
18. Porsolt R.D. Animal models of depression: utility for transgenic research. Rev. Neurosci. 11:2000;53-58.
19. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
20. Porsolt R.D., Bertin A., Blavet N., Deniel M., Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57:1979;201-210.
21. Rainer M., Kraxberger E., Haushofer M., Mucke H.A.M., Jellinger K.A. No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia. J. Neural. Transm. 107:2000;1475-1481.
22. Reneric J.P. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Neuropsychopharmacology. 24:2001;379-390.
23. Rex A., Hentschke M.P., Fink H. Bioavailability of reduced nicotinamide-adenine-dinucleotide (NADH) in the central nervous system of the anaesthetized rat measured by laser-induced fluorescence spectroscopy. Pharmacol. Toxicol. 90:2002;220-225.
24. Vrecko K., Birkmayer J.G., Krainz J. Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adenine dinucleotide (NADH). J. Neural. Transm. 5:1993;147-156.
25. Vrecko K., Storga D., Birkmayer J.G., Moller R., Tafeit E., Horejsi R.et al. NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells. Biochim. Biophys. Acta. 1361:1997;59-65.
26. Willner P. The validity of animal models of depression. Psychopharmacology. 83:1984;1-16.
27. Willner P. Animal models of depression: an overview. Pharmacol. Ther. 45:1990;425-455.